www.fdanews.com/articles/82085-hikma-pharmaceuticals-says-plans-london-ipo
HIKMA PHARMACEUTICALS SAYS PLANS LONDON IPO
November 1, 2005
Generic drug company Hikma Pharmaceuticals said on Monday it planned to float on the London Stock Exchange with a price range of 265 to 330 pence, the middle of which values it at about 500 million pounds ($874.9 million).